Find a
Schedule an 

New Eye Drop Treatment in Development for AMD

Upload: December 1, 2015Researchers at Harvard University’s Beth Israel Deaconess Medical Center (BIDMC) and the University of New Mexico in the US are experimenting with a new eye drop treatment called Vasotide. This drug is expected to treat retinal conditions, such as age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). Early results show Vasotide reduces inflammation and branching of new blood vessels in animal models of wet AMD and ROP, and this exciting new research could soon move to human trials.

Current treatments for such retinal disorders are delivered as injections into the eye, which are quite expensive and can cause some patients a tremendous amount of discomfort. Vasotide is currently administered as an eye drop and as a subcutaneous injection in the animal trials; surprisingly, early results show that the Vasotide drops are as equally effective as the injections. Researchers also plan on administering the drug as self-dissolving contact lenses during the human trials. If the human trials of the drug are successful, researchers hope that the various non-injection Vasotide formulations will replace repetitive intra-ocular injections, reducing their cost and the uncomfortable experience for patients. The findings of this study thus far are published in Science Transitional Medicine.

Are You A lasik candidate?
Cataract Lifestyle Questionnaire
Are You Interested in Cosmetic Surgery For Your Eyes?

*Use our secure online portal to refer your patients. It is easy to use, completely secure, and utilizes digital communications to update you on the status of all your referrals and allows you to have 2-way digital communication with NTEC/Prism. This same portal keeps your patients updated on their appointments.

Contact Us

Our Services and Direct Contact

Main Line: 416-748-2020

General and Appointments:
Main Line or 416-748-4858 or

Cataract, Pterygium, Cornea Surgery:
Ext #308 or 320 or

Eyelid Surgery:
Ext #306 or

Ext #309 or

LASIK, Crosslinking, and Intacs:
Ext #319 or

Ext #305 or